Author

S. Ponnazhagan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Hurley· 1 shared B. Moyo· 1 shared D. Curiel· 1 shared G. Bao· 1 shared H. Wang· 1 shared J. H. Lee· 1 shared L. Rome· 1 shared L. T. Collins· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Hurley

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Encapsulation of AAVs into protein vault nanoparticles as a novel solution to gene therapy's neutralizing antibody problem

L. T. Collins, W. Beatty, B. Moyo, M. Alves-Bezerra, A. Hurley, Q. Lou, Z. H. Zhou, W. Lagor, G. Bao, S. Ponnazhagan, R. McNally, L. Rome, D. Curiel

This study encapsulates AAVs into protein vault nanoparticles to bypass neutralizing antibodies, enabling effective gene therapy despite preexisting immunity.

bioRxiv · Nov 29, 2023 · PreprintBioengineering

Structural determinants and genetic modifications enhance BMP2 stability and extracellular secretion

S. Ponnazhagan, V. Khattar, J. H. Lee, H. Wang, S. Bastola

This study identifies lysine residues critical for BMP2 degradation and shows genetic modifications can enhance its stability and extracellular secretion.

bioRxiv · Jul 20, 2018Cell Biology